Provided by Tiger Trade Technology Pte. Ltd.

Altimmune, Inc.

3.50
+0.08002.34%
Volume:1.07M
Turnover:3.70M
Market Cap:455.25M
PE:-3.50
High:3.52
Open:3.43
Low:3.41
Close:3.42
52wk High:7.73
52wk Low:2.90
Shares:130.07M
Float Shares:124.00M
Volume Ratio:0.84
T/O Rate:0.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9999
EPS(LYR):-0.9999
ROE:-50.57%
ROA:-28.17%
PB:2.02
PE(LYR):-3.50

Loading ...

ANDE Smart Supply Chain Sees Surge in Bank Loans: Backed by Midea with Billions in Related Transactions Annually, Continues Dividends of Nearly 600 Million

Deep News
·
Oct 14, 2025

Altimmune Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
Oct 10, 2025

Altimmune Inc. Files Initial Beneficial Ownership Statement for Chief Medical Officer Christophe Arbet-Engels

Reuters
·
Oct 04, 2025

Altimmune Appoints Christophe Arbet-Engels as Chief Medical Officer; Dr. Scott Harris to Transition to Senior Strategic Advisor Ahead of 2026 Retirement

Reuters
·
Oct 04, 2025

Altimmune Inc. Faces Class Action Lawsuit Over Alleged Securities Fraud Filed by Shareholders

Reuters
·
Oct 01, 2025

ALT Resources PLC Announces General Meeting to Amend Articles of Association

TIPRANKS
·
Oct 01, 2025

Altimmune appoints Christophe Arbet-Engels as CMO

TIPRANKS
·
Sep 29, 2025

Press Release: Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide

Dow Jones
·
Sep 29, 2025

Altimmune Inc. Announced Results of Annual Meeting of Stockholders

Reuters
·
Sep 26, 2025

ALT Lawsuit Alert! Class Action Lawsuit Against Altimmune

TIPRANKS
·
Sep 24, 2025

New Data for BRIUMVI® Demonstrate 89.9% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 6 Years of Continuous BRIUMVI Treatment

GlobeNewswire
·
Sep 24, 2025

This Week's Unlock Data Overview: PARTI, NIL, SAHARA to Experience One-Time Large Unlock

Blockbeats
·
Sep 22, 2025